Search

Your search keyword '"Docetaxel -- Research"' showing total 513 results

Search Constraints

Start Over You searched for: Descriptor "Docetaxel -- Research" Remove constraint Descriptor: "Docetaxel -- Research"
513 results on '"Docetaxel -- Research"'

Search Results

51. Findings from Hacettepe University in Nanocapsules Reported (Oral Docetaxel Delivery With Cationic Polymeric Core-shell Nanocapsules: In Vitro and In Vivo Evaluation)

52. Researcher from Chung-Ang University Reports Recent Findings in Cancer (Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells)

53. Study Findings on Mitotic Inhibitors Published by a Researcher at Waikato Hospital (A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study)

54. Shiraz University of Medical Sciences Researchers Provide New Study Findings on Adenocarcinoma (Characterization and Evaluation of Nano-niosomes Encapsulating Docetaxel against Human Breast, Pancreatic, and Pulmonary Adenocarcinoma Cancer Cell ...)

55. Mustansiriyah University Researchers Discuss Research in Arthritis (Effect of Docetaxel on Matrix Metalloproteinase 1 Expression in Freund's Adjuvant Induced Arthritis)

56. Reports Summarize Non-Small Cell Lung Cancer Findings from University of Texas MD Anderson Cancer Center (Clinical Benefit From Docetaxel Plus /- Ramucirumab Is Not Associated With Mutation Status In Metastatic Non-small-cell Lung Cancer ...)

57. Research on Prostate Cancer Described by Researchers at University Hospital Carl Gustav Carus (Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines)

58. Research Data from University of Turin Update Understanding of Breast Cancer (RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment)

59. Findings from University of Selcuk Broaden Understanding of Breast Cancer (Comparison With Molecular Effects of Ukrain, Tamoxifen, and Docetaxel On Human Breast Cancer Cell Lines)

60. Study Results from Islamic Azad University Provide New Insights into Cancer (Synthesis of Pamam Dendrimers Anchored To Ws2 Nano-sheets for Controlled Delivery of Docetaxel: Design, Characterization and In Vitro Drug Release)

61. Study Findings on Breast Cancer Detailed by Researchers at University of Campinas (UNICAMP) (Docetaxel Loaded in Copaiba Oil-Nanostructured Lipid Carriers as a Promising DDS for Breast Cancer Treatment)

62. Study Data from Zhejiang University Provide New Insights into Prostate Cancer (Mir-195 Regulated By Neat1 Attenuates the Docetaxel Resistance and Metastasis of Prostate Cancer Cells Through Downregulating Usp22)

63. Investigators at Xi'an Jiaotong University Detail Findings in Breast Cancer (Efficacy and Safety of Concurrent Chemoradiotherapy With Docetaxel for Locally Advanced Breast Carcinoma After Modified Radical Mastectomy)

64. Recent Findings from West Anhui University Has Provided New Information about Cancer (Nitric Oxide-releasing Docetaxel Prodrug Nanoplatforms for Effective Cancer Therapy)

65. Recent Findings from University of Health Sciences Turkey Highlight Research in Prostate Cancer (Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer)

67. Researchers from Wenzhou Medical University Detail New Studies and Findings in the Area of Breast Cancer (Preparation, Characterization and Application of Docetaxel-loaded Methoxy Polyethylene Glycol-octacosanol Micelles for Breast Cancer ...)

68. Findings from Fudan University Broaden Understanding of Breast Cancer (Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel * * via* * ...)

69. Studies from Fudan University Yield New Data on Breast Cancer (Hypoxia Induces Docetaxel Resistance In Triple-negative Breast Cancer Via the Hif-1 Alpha/mir-494/survivin Signaling Pathway *)

70. Findings from Seoul National University Provides New Data on Lung Cancer (Ckd-516 Potentiates the Anti-cancer Activity of Docetaxel Against Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-resistant Lung Cancer)

71. Findings from Hiroshima University Has Provided New Data on Breast Cancer (Febrile Neutropenia and Role of Prophylactic Granulocyte Colony-stimulating Factor In Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer)

72. Reports Outline Anticancer Agents Study Results from Bahauddin Zakariya University (Biodegradable Magnetic Molecularly Imprinted Anticancer Drug Carrier for the Targeted Delivery of Docetaxel)

73. New Urothelial Cancer Study Findings Recently Were Reported by Researchers at University of Iowa (Sequential Endoluminal Gemcitabine and Docetaxel for the Treatment of Clinically Non-invasive High-grade Upper Tract Urothelial Carcinoma)

74. Kyoto Prefectural University of Medicine Researcher Publishes New Studies and Findings in the Area of Non-Small Cell Lung Cancer (Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With ...)

75. New Nanoparticles Findings from Xinxiang Medical University Outlined [Docetaxel-loaded Redox-sensitive Nanoparticles Self-assembling From Poly(Caprolactone) Conjugates With Disulfide-linked Poly(Ethylene Glycol)]

76. Children's Hospital - Zhengzhou University Researchers Reveal New Findings on Nanoparticles (Glucose-Modified Zein Nanoparticles Enhance Oral Delivery of Docetaxel)

77. Studies from Soochow University Update Current Data on Prostate Cancer (Long Non-coding Rna Pcdrinc1 Confers Docetaxel Resistance In Prostate Cancer By Promoting Autophagy)

78. Investigators at Dalian Medical University Report Findings in Ovarian Cancer (Clinical Efficacy and Safety of Docetaxel In Combination With Cisplatin On the Platin-sensitive Recurrent Ovarian Cancer In Comparison of Whole Abdominal Radiotherapy)

79. Studies from Guangdong Provincial People's Hospital in the Area of Nasopharyngeal Carcinoma Reported (Functional Drug Carriers Formed By Rgd-modified Beta-cd-hpg for the Delivery of Docetaxel for Targeted Inhibition of Nasopharyngeal Carcinoma ...)

80. Findings from First Affiliated Hospital of Nanjing Medical University Provide New Insights into Prostate Cancer (Ferroptosis Induction Improves the Sensitivity of Docetaxel in Prostate Cancer)

81. Findings on Breast Cancer Detailed by Investigators at Jamia Hamdard [Designing and Development of Omega-3 Fatty Acid Based Self-nanoemulsifying Drug Delivery System (Snedds) of Docetaxel With Enhanced Biopharmaceutical Attributes for Management ...]

82. Recent Studies from Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University Add New Data to Non-Small Cell Lung Cancer (Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung ...)

83. New Findings Reported from University of North Texas Describe Advances in Mitotic Inhibitors (Design and Evaluation of Two-step Biorelevant Dissolution Methods for Docetaxel Oral Formulations)

84. New Gastric Cancer Study Findings Reported from Gazi University (Does Docetaxel Matter In Metastatic Gastric Cancer? Folfox Versus Flot Regimens As First-line Treatment)

85. Jazan University Researchers Update Knowledge of Breast Cancer (Self-Assembled Nanomicellar Formulation of Docetaxel as a Potential Breast Cancer Chemotherapeutic System)

86. Data on Gastric Cancer Reported by Researchers at Antoni Van Leeuwenhoek Hospital (Systemic Exposure of Oxaliplatin and Docetaxel In Gastric Cancer Patients With Peritonitis Carcinomatosis Treated With Intraperitoneal Hyperthermic Chemotherapy)

87. New Mitotic Inhibitors Findings from Polish Academy of Sciences Described (Docetaxel-loaded Scaffolds Manufactured By 3d Printing As Model, Biodegradable Prostatic Stents)

88. University of Naples Federico II Researchers Report on Findings in Drug Delivery Systems (Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors)

89. New Prostate Cancer Research from Universite Claude Bernard Lyon 1 Outlined (Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/- Docetaxel)

90. Findings in the Area of Breast Cancer Reported from Islamic Azad University (Fabrication and Investigation Potential Effect of Lentinan and Docetaxel Nanofibers for Synergistic Treatment of Breast Cancer In Vitro)

91. Data on Breast Cancer Detailed by Researchers at Islamic Azad University (Combination Therapy Against Breast Cancer Cells by Docetaxel With Rosmarinic and Thymoquinone: An Experimental Study)

92. Medical University of Lublin Researcher Describes Advances in Cell Line (Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel)

93. New Findings on Non-Small Cell Lung Cancer Described by Investigators at German Centre for Lung Research (DZL) (Clinical Outcomes of Ramucirumab Plus Docetaxel In the Treatment of Patients With Non-small Cell Lung Cancer After Immunotherapy: a ...)

95. New Findings from Bharti Vidyapeeth Deemed University Medical College in Ovarian Cancer Provides New Insights (Vacuum Foam Drying of Docetaxel Mixed Micelles for Improved Stability and Ovarian Cancer Treatment)

96. Studies from Southern Medical University Further Understanding of Cancer Gene Therapy [Combined Integrin Alpha(V)Beta(3) and Lactoferrin Receptor Targeted Docetaxel Liposomes Enhance the Brain Targeting Effect and Anti-glioma Effect]

97. Study Findings on Breast Cancer Described by Researchers at Central South University (Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients-A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial)

98. New Zafirlukast Therapy Research from First Affiliated Hospital of Jinzhou Medical University Outlined [Zafirlukast ameliorates Docetaxel-induced activation of NOD-like receptor protein 3 (NLRP3) inflammasome, mediated by sirtuin1 (SIRT1) in ...]

99. Studies from University of California Davis Provide New Data on Prostate Cancer (Activation of the Abcb1 Amplicon In Docetaxel- and Cabazitaxel-resistant Prostate Cancer Cells)

100. New Prostate Cancer Research Reported from University of Wisconsin Madison [Oligo(Lactic Acid) [ [8] ] -Docetaxel Prodrug-Loaded PEG-* * b* * -PLA Micelles for Prostate Cancer]

Catalog

Books, media, physical & digital resources